Current Pain and Headache Reports最新文献_第3页

Stellate Ganglion Block in the Treatment of Long COVID: A Systematic Review. 星状神经节阻滞治疗长冠状病毒：系统评价。

IF 3.5 2区医学

Current Pain and Headache Reports Pub Date : 2026-04-13 DOI: 10.1007/s11916-026-01477-5

Sudeep Peddireddy, Noah VanWingerden, Priya Patel, Gabriel Howard, Jeffrey Berger

{"title":"Stellate Ganglion Block in the Treatment of Long COVID: A Systematic Review.","authors":"Sudeep Peddireddy, Noah VanWingerden, Priya Patel, Gabriel Howard, Jeffrey Berger","doi":"10.1007/s11916-026-01477-5","DOIUrl":"10.1007/s11916-026-01477-5","url":null,"abstract":"Objectives: This review evaluates stellate ganglion block as a treatment for long COVID, seeking to evaluate the treatment's efficacy by various symptoms and the limitations of the current literature.Study design: Systematic Review.Setting: Ambulatory or Outpatient Setting.Methods, subjects: A systematic review of the current literature regarding use of stellate ganglion block in patients with long COVID was conducted. 2 databases were searched on August 28th, 2025. Search terms were \"long COVID\" and \"stellate ganglion block\", yielding 45 results. Studies examining patient outcomes after stellate ganglion block were included. Case reports, case series, basic science studies and previous reviews were excluded. Seven studies met inclusion criteria.Results: Patients received a single stellate ganglion block in some studies and multiple stellate ganglion blocks in others. All studies reported symptomatic improvement without control groups. Response rates ranged from 55.8% to 100%. The most robust improvements (> 80% patients reporting relief) were seen in cough, dyspnea, headache, joint pain, pain interference/intensity, pins/needles, subjective relief.Conclusion: Stellate ganglion block is a promising treatment that appears to generate substantive benefit for many of the symptoms seen in long COVID. However, the current literature has small, uncontrolled studies with heterogenous study designs and follow-up periods. Standardized research with larger sample sizes, control groups, and longer-term follow up is necessary to elucidate the degree of benefit. IRB approval and clinical trial registration not required.","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13076556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147678457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Review of Chronic Post-Sternotomy Pain Syndrome. 慢性胸骨切开后疼痛综合征的研究进展。

IF 3.5 2区医学

Current Pain and Headache Reports Pub Date : 2026-04-13 DOI: 10.1007/s11916-026-01483-7

Richard Bui, Arusa Macnojia, Tommy Li, Jamal Hasoon, Ali Khalifa, Anvinh Nguyen

引用次数: 0

Disparities in Headache Care and Research in Children and Adolescents: A Narrative Review. 儿童和青少年头痛护理和研究的差异：叙述性回顾。

IF 3.5 2区医学

Current Pain and Headache Reports Pub Date : 2026-04-13 DOI: 10.1007/s11916-026-01479-3

Bradley Ong, Fardin Khan, Nan Cheng, Rashmi B Halker Singh, Juliana H VanderPluym

引用次数: 0

Buprenorphine Microinduction Treatment in Tri-Diagnosis Patients with Opioid Use Disorder and Chronic Non-Cancerous Pain. 丁丙诺啡微诱导治疗阿片类药物使用障碍和慢性非癌性疼痛的三诊断患者。

IF 3.5 2区医学

Current Pain and Headache Reports Pub Date : 2026-04-10 DOI: 10.1007/s11916-026-01478-4

Paul Lynch, Austin Murphy, Anisa Syed, Madelyn Reilly, Alaa Abd-Elsayed

{"title":"Buprenorphine Microinduction Treatment in Tri-Diagnosis Patients with Opioid Use Disorder and Chronic Non-Cancerous Pain.","authors":"Paul Lynch, Austin Murphy, Anisa Syed, Madelyn Reilly, Alaa Abd-Elsayed","doi":"10.1007/s11916-026-01478-4","DOIUrl":"https://doi.org/10.1007/s11916-026-01478-4","url":null,"abstract":"Tri-diagnosis patients cause prevalent economic and healthcare burdens. A tri-diagnosis patient presents with three concurrent conditions: a mental illness, a substance use disorder, and an additional chronic medical condition. The medical conditions of interest include chronic non-cancerous pain (CNCP) and co-occurring with opioid use disorder (OUD). These patients are complex to treat, and an intensive outpatient program (IOP) would be appropriate to address the severity of their symptoms. OUD is prevalent among this population, especially for those in poverty, and in the United States generally. However, it is not fully addressed in the United States, and for those who receive treatment, only 25% will receive medication-assisted treatment. Buprenorphine Microdosing Induction (BPMI), often referred to as the Bernese method, is a novel approach traditionally used in opioid use disorder (OUD) treatment. It can serve as medication-assisted treatment for OUD treatment and pain management simultaneously in an IOP. Because buprenorphine is a partial-opioid agonist, it mitigates withdrawal symptoms and side effects of opioid withdrawal while still providing analgesic effects. Furthermore, this article describes the protocol of BPMI for tri-diagnosis patients who are struggling with OUD and chronic pain and explores the substantial positive outcomes and higher efficacy in contrast to opioids.","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147647270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cognitive Dysfunction in Migraine: Underlying Mechanisms and Clinical Implications. 偏头痛的认知功能障碍：潜在机制和临床意义。

IF 3.5 2区医学

Current Pain and Headache Reports Pub Date : 2026-04-10 DOI: 10.1007/s11916-026-01466-8

Ami Cuneo, Carrie E Robertson, Jennifer I Stern, Daniel Krashin, Aysha Siddika, Natalia Murinova

引用次数: 0

Efficacy and Risks of Intradiscal Electrothermal Therapy (IDET) for Treatment of Low Back Pain: A Narrative Review. 椎间盘内电热疗法（IDET）治疗腰痛的疗效和风险：一个叙述性的回顾。

IF 3.5 2区医学

Current Pain and Headache Reports Pub Date : 2026-04-09 DOI: 10.1007/s11916-026-01474-8

Adam Litch, Austin Thomassen, Sanjana Sudini, Ahmed I Anwar, Kalob M Broocks, Zachary R Palowsky, Shahab Ahmadzadeh, Azem A Chami, Sahar Shekoohi, Alaa Abd-Elsayed, Alan D Kaye

引用次数: 0

Headache Attributed to Infection: A Clinical and Pathophysiological Overview. 由感染引起的头痛：临床和病理生理综述。

IF 3.5 2区医学

Current Pain and Headache Reports Pub Date : 2026-04-08 DOI: 10.1007/s11916-026-01473-9

Márk Kozák, Laszlo Mechtler, Christopher Ralyea, Viktor Bencs, Rebeka Hodossy-Takács, István Várkonyi

引用次数: 0

Epidemiology, Risk Factors, and Management of Pregnancy-Related Chronic Back Pain. 妊娠相关慢性背痛的流行病学、危险因素和管理。

IF 3.5 2区医学

Current Pain and Headache Reports Pub Date : 2026-03-24 DOI: 10.1007/s11916-026-01470-y

Helen S Jung, Franzes Anne Z Liongson, Alexandra Fonseca, Claire Yuan, Alexandra Therond, Paul J Christo, Anvinh Nguyen, Ronald J Kulich, Jamal J Hasoon, Christopher L Robinson

引用次数: 0

Selective NaV1.8 Inhibition for Pain Management: Current Evidence and Future Potential of Suzetrigine. 选择性抑制疼痛管理：suzetriine的现有证据和未来潜力。

IF 3.5 2区医学

Current Pain and Headache Reports Pub Date : 2026-03-17 DOI: 10.1007/s11916-026-01472-w

Alaa Abd-Elsayed, Nina Hashimoto, Madelyn Reilly, Danielle Kohr, Muhammed Zahid Sahin

引用次数: 0

An Updated Review of Utilization Patterns of Sacroiliac Joint Interventions in the Fee-for-service (ffs) Medicare Population from 2000 to 2022. 2000 - 2022年自费医疗保险人群骶髂关节干预使用模式的最新回顾

IF 3.5 2区医学

Current Pain and Headache Reports Pub Date : 2026-03-14 DOI: 10.1007/s11916-026-01468-6

Laxmaiah Manchikanti, Vidyasagar Pampati, Alan D Kaye, Alaa Abd-Elsayed, Sahar Shekoohi, Mahendra R Sanapati, Amol Soin, Joshua A Hirsch

引用次数: 0